These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23466572)

  • 21. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of chronic kidney disease on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. A long-term single-center mortality study.
    Peyracchia M; Scacciatella P; Conrotto F; Meynet I; Biava LM; Budano C; Pennone M; D'Amico M; Gaita F
    Minerva Cardioangiol; 2018 Feb; 66(1):6-15. PubMed ID: 28948753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
    Chinnadurai R; Clarke NW; Kalra PA
    BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.
    Tomaszuk-Kazberuk A; Nikas D; Lopatowska P; Młodawska E; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Sobkowicz B; Goudevenos I
    Kidney Blood Press Res; 2018; 43(6):1796-1805. PubMed ID: 30504712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel.
    Morel O; El Ghannudi S; Jesel L; Radulescu B; Meyer N; Wiesel ML; Caillard S; Campia U; Moulin B; Gachet C; Ohlmann P
    J Am Coll Cardiol; 2011 Jan; 57(4):399-408. PubMed ID: 21251579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease.
    Patel KK; Shah SY; Arrigain S; Jolly S; Schold JD; Navaneethan SD; Griffin BP; Nally JV; Desai MY
    J Am Heart Assoc; 2019 Feb; 8(3):e009980. PubMed ID: 30686093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.
    Dohi T; Kasai T; Miyauchi K; Takasu K; Kajimoto K; Kubota N; Amano A; Daida H
    J Cardiol; 2012 Dec; 60(6):438-42. PubMed ID: 23063662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of age and CKD with prognosis of myocardial infarction.
    Choi JS; Kim MJ; Kang YU; Kim CS; Bae EH; Ma SK; Ahn YK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Kim SW;
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):939-44. PubMed ID: 23430208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    Bansal N; Zelnick L; Bhat Z; Dobre M; He J; Lash J; Jaar B; Mehta R; Raj D; Rincon-Choles H; Saunders M; Schrauben S; Weir M; Wright J; Go AS;
    J Am Coll Cardiol; 2019 Jun; 73(21):2691-2700. PubMed ID: 31146814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
    Chang YT; Wu HL; Guo HR; Cheng YY; Tseng CC; Wang MC; Lin CY; Sung JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study.
    Ramezankhani A; Tohidi M; Azizi F; Hadaegh F
    J Transl Med; 2017 Nov; 15(1):240. PubMed ID: 29183386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Skeletal Muscle Mass on Long-Term Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
    Harada K; Suzuki S; Ishii H; Aoki T; Hirayama K; Shibata Y; Negishi Y; Sumi T; Kawashima K; Kunimura A; Shimbo Y; Tatami Y; Kawamiya T; Yamamoto D; Morimoto R; Yasuda Y; Murohara T
    Am J Cardiol; 2017 Apr; 119(8):1275-1280. PubMed ID: 28215411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
    Aoki T; Ishii H; Tanaka A; Suzuki S; Ichimiya S; Kanashiro M; Murohara T
    Clin Exp Nephrol; 2019 Feb; 23(2):182-188. PubMed ID: 30218297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
    Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.